Wealth Enhancement Advisory Services, LLC Biomarin Pharmaceutical Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 44,584 shares of BMRN stock, worth $2.59 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,584
Previous 23,201
92.16%
Holding current value
$2.59 Million
Previous $1.53 Million
106.62%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.32 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.1 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.03 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$869 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$627 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...